Showing 2,281 - 2,300 results of 102,454 for search '(( a web decrease ) OR ( 5 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.02s Refine Results
  1. 2281
  2. 2282
  3. 2283
  4. 2284
  5. 2285

    The TLR4 activator LPS decreases photoreceptor viability and reducesWnt-mediated protection from oxidative stress. by Hyun Yi (57741)

    Published 2012
    “…White bars, no H<sub>2</sub>O<sub>2</sub>; black bars, with H<sub>2</sub>O<sub>2</sub>. Mean ± SD, *p<0.05 no additions with H<sub>2</sub>O<sub>2</sub> (n = 5) compared with Wnt3a (n = 4); #p<0.05 50 µg/ml LPS+Wnt3a (n = 5) compared with Wnt3a+ H<sub>2</sub>O<sub>2</sub> (n = 4). …”
  6. 2286
  7. 2287

    Blockade of CB<sub>1</sub> receptors does not prevent the anandamide-induced decrease in locomotor activity and rearing. by Adriaan W. Bruijnzeel (2605954)

    Published 2016
    “…<p>Rats were treated with rimonabant (5 mg/kg, ip) and anandamide (10 mg/kg, ip) and horizontal (A) and vertical beam breaks (B) were assessed in the small open field. …”
  8. 2288
  9. 2289
  10. 2290
  11. 2291
  12. 2292

    <i>S.</i> Typhimurium-infected mice have tissue inflammation and thrombosis, increased hematopoiesis, and decreased splenic iron. by Diane E. Brown (160264)

    Published 2013
    “…(B) Mouse spleen, 3 weeks post-infection; extramedullary hematopoiesis (EMH; arrow, megakaryocytes), histiocytic infiltration (I) throughout the red pulp, and thrombus (T). H&E stain (A, B). (C) Spleen, mock-infected (left) and infected mouse (right), 3 weeks post-infection; markedly decreased ferric iron staining in red pulp. …”
  13. 2293

    Antagonizing BMP type I receptors decreases cell growth, proliferation, and clonogenicity of lung cancer cell lines. by Elaine Langenfeld (402034)

    Published 2013
    “…<p>(<b>A</b>) A549 and H1299 cells cultured in DMEM 5% FCS were treated with DMSO, 10 µM Dorsomorphin, 1 µM DMH1, 1 µM DMH2, or 1 µM LDN for 7 days and cell counts performed. …”
  14. 2294
  15. 2295
  16. 2296
  17. 2297

    The NK1-receptor antagonist ezlopitant significantly decreases the breakpoint for sucrose but not ethanol operant self-administration in rats. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant (5 and 10 mg/kg i.p.) decreases the breakpoint for 5% sucrose using a PR schedule (<b>A</b>), but had no effect on the breakpoint for 10% ethanol (<b>B</b>). …”
  18. 2298
  19. 2299
  20. 2300